Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 3/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | BRAF | P15056 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3693551 | 0.79 | ERN1 (0.39) | ERN1NPBWR1NT5EGRM5 | |
| SCHEMBL3683451 | 0.78 | ERN1 (0.38) | ERN1NPBWR1NT5EPIK3CDGRM5 | |
| SCHEMBL3688421 | 0.75 | ERN1 (0.36) | ERN1NPBWR1NT5EGRM5 | |
| SCHEMBL3689147 | 0.75 | CSNK2A1 (0.36) | ERN1NPBWR1NT5EGRM5 | |
| SCHEMBL1583247 | 0.74 | ERN1 (0.40) | ERN1NPBWR1NT5E | |
| SCHEMBL1583278 | 0.73 | ERN1 (0.40) | ERN1NPBWR1NT5E | |
| SCHEMBL3693692 | 0.73 | ERN1 (0.40) | ERN1NPBWR1NT5E | |
| Potassium Ion SCHEMBL1583281 | 0.72 | ERN1 (0.39) | ERN1NPBWR1NT5E | |
| SCHEMBL3793277 | 0.71 | NOTUM (0.41) | ERN1 | |
| SCHEMBL3789342 | 0.70 | ERN1 (0.38) | ERN1NPBWR1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100204265-A1 | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections | GENELABS TECHNOLOGIES, INC. | 2010-08-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204265-A1 | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections | OAT, HAVCR2, CPS1 | ERN1 237/4885NPBWR1 3024/4885NT5E 171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.